Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Ronald, Kalmeijer"'
Autor:
Harry L A Janssen, Jinlin Hou, Tarik Asselah, Henry L Y Chan, Fabien Zoulim, Yasuhito Tanaka, Ewa Janczewska, Ronald G Nahass, Stefan Bourgeois, Maria Buti, Pietro Lampertico, Oliver Lenz, Thierry Verbinnen, Joris Vandenbossche, Willem Talloen, Ronald Kalmeijer, Maria Beumont, Michael Biermer, Umesh Shukla
Publikováno v:
Gut. BMJ Publishing Group
Scientia
Scientia
ObjectiveWe present the final analysis results of the phase 2 JADE study (ClinicalTrials.gov Identifier:NCT03361956).Design232 patients with chronic hepatitis B (CHB) not currently treated at study start (NCT) at study start or virologically suppress
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f702b8cc4a17edfe62562c85466ffa3f
https://doi.org/10.1136/gutjnl-2022-328041
https://doi.org/10.1136/gutjnl-2022-328041
Autor:
Man-Fung Yuen, Stephen Locarnini, Tien Huey Lim, Simone I. Strasser, William Sievert, Wendy Cheng, Alex J. Thompson, Bruce D. Given, Thomas Schluep, James Hamilton, Michael Biermer, Ronald Kalmeijer, Maria Beumont, Oliver Lenz, Filip De Ridder, Gavin Cloherty, Danny Ka-Ho Wong, Christian Schwabe, Kathy Jackson, Ching Lung Lai, Robert G. Gish, Edward Gane
Publikováno v:
Journal of Hepatology. 77:1287-1298
RNA interference therapy has been shown to reduce hepatitis B surface antigen (HBsAg) levels in preclinical models, which could confer functional cure in patients with chronic hepatitis B. This phase IIa trial (ClinicalTrials.gov Identifier: NCT03365
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::479448f9f509e9a64dd4d4daf760b90d
https://doi.org/10.1016/j.jhep.2022.07.010
https://doi.org/10.1016/j.jhep.2022.07.010
Autor:
Edward J. Gane, Edwin DeJesus, Ewa Janczewska, Jacob George, Moises Diago, Mariliza Hendrique Da Silva, Henk Reesink, Igor Nikitin, Holger Hinrichsen, Stefan Bourgeois, Peter Ferenci, Umesh Shukla, Ronald Kalmeijer, Oliver Lenz, Bart Fevery, Chris Corbett, Maria Beumont, Wolfgang Jessner
Publikováno v:
BMC Infectious Diseases, Vol 17, Iss 1, Pp 1-13 (2017)
Abstract Background This Phase 3, open-label, rollover study (NCT01323244) investigated the efficacy and safety of simeprevir plus peginterferon α-2a (PegIFNα-2a) and ribavirin (RBV) in a well-characterized population of HCV genotype 1 (GT1)-infect
Externí odkaz:
https://doaj.org/article/3cfa6244d4a94f6ba954c69bc057268c
Autor:
Man-Fung Yuen, Tarik Asselah, Ira M Jacobson, Maurizia Brunetto, Harry Janssen, Tetsuo Takehara, Jinlin Hou, Thomas Kakuda, Tom Lambrecht, Ronald Kalmeijer, Carine Guinard-Azadian, Cristiana Mayer, John Jerzorwski, Thierry Verbinnen, Oliver Lenz, Umesh Shukla, Michael Biermer
Publikováno v:
Journal of Hepatology. 77:S864-S865
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1b2f42d8a66e1415247db0634068cb5a
https://doi.org/10.1016/s0168-8278(22)02024-4
https://doi.org/10.1016/s0168-8278(22)02024-4
Autor:
Huybrecht T’jollyn, Nele Goeyvaerts, Thomas Kakuda, Louis Sandra, Tetsuro Ogawa, Joris J Vandenbossche, Xavier Woot de Trixhe, Oliver Lenz, Ronald Kalmeijer, Michael Biermer, Juan Jose Perez Ruixo, Oliver Ackaert
Publikováno v:
Journal of Hepatology. 77:S838-S839
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::43bebe82afca3e58ac9cd9e45830dd2b
https://doi.org/10.1016/s0168-8278(22)01972-9
https://doi.org/10.1016/s0168-8278(22)01972-9
Autor:
Kosh Agarwal, Maria Buti, Florian van Bömmel, Pietro Lampertico, Ewa Janczewska, Marc Bourliere, Thomas Vanwolleghem, Oliver Lenz, Thierry Verbinnen, Thomas Kakuda, Cristina Mayer, John Jerzorwski, Maria Beumont-Mauviel, Ronald Kalmeijer, Michael Biermer, Isabelle Lonjon-Domanec
Publikováno v:
Journal of Hepatology. 77:S8
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a54a0514597038645e8d4a032577e66c
https://doi.org/10.1016/s0168-8278(22)00437-8
https://doi.org/10.1016/s0168-8278(22)00437-8
Autor:
Ceyhun Bicer Ceyhun, John F. Dillon John, Maria Beumont Maria, Isabelle Lonjon-Domanec Isabelle, Michael Schlag Michael, Catherine Nalpas Catherine, Stefan Mauss Stefan, Ronald Kalmeijer Ronald, Wolfgang Jessner Wolfgang
Publikováno v:
Pharmateca. :32-40
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9eed22636988d2daf4a977571440d429
https://doi.org/10.18565/pharmateca.2018.9.32-40
https://doi.org/10.18565/pharmateca.2018.9.32-40
Autor:
Harry Janssen, Jinlin Hou, Tarik Asselah, Henry Chan, Fabien Zoulim, Yasuhito Tanaka, Ewa Janczewska, Ronald Nahass, Stefan Bourgeois, Maria Buti, Pietro Lampertico, Oliver Lenz, Thierry Verbinnen, Joris J. Vandenbossche, Willem Talloen, Michael Biermer, Ronald Kalmeijer, Maria Beumont-Mauviel, Umesh Shukla
Publikováno v:
Journal of Hepatology. 73:S129-S130
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3ca3a312e35b8070bb2939fa9873d45a
https://doi.org/10.1016/s0168-8278(20)30773-x
https://doi.org/10.1016/s0168-8278(20)30773-x
Autor:
Fiona, Marra, Christoph, Höner Zu Siederdissen, Saye, Khoo, David, Back, Michael, Schlag, Sivi, Ouwerkerk-Mahadevan, Ceyhun, Bicer, Isabelle, Lonjon-Domanec, Wolfgang, Jessner, Maria, Beumont-Mauviel, Ronald, Kalmeijer, Markus, Cornberg
Publikováno v:
British Journal of Clinical Pharmacology
Aims Direct‐acting antiviral agents (DAAs) for the treatment of hepatitis C (HCV) can be associated with drug–drug interactions (DDIs) with concomitant medications. The practical clinical implications of such DDIs are poorly understood. We assess
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2f071be30270da6029024a2b808acccb
https://pubmed.ncbi.nlm.nih.gov/29345798
https://pubmed.ncbi.nlm.nih.gov/29345798
Autor:
Lai, Wei, Tao, Han, Dongliang, Yang, Jeong, Heo, Jia, Shang, Jun, Cheng, Xinyue, Chen, Qing, Xie, Ju-Hyun, Kim, Ronald, Kalmeijer, Sivi, Ouwerkerk-Mahadevan, Eva, Hoeben, Oliver, Lenz, Thierry, Verbinnen, Rekha, Sinha, MengChun, Li, Jane, Scott, Monika, Peeters, James, Witek
Publikováno v:
Journal of gastroenterology and hepatology. 31(5)
Approximately one-third of patients with hepatitis C virus (HCV) genotype (GT) 1 infection live in East Asia. This study evaluated the efficacy, pharmacokinetics, safety, and tolerability of simeprevir plus peginterferon alpha-2a and ribavirin (PR) i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::eda869ac6c23f429044899d2ad4b8849
https://pubmed.ncbi.nlm.nih.gov/26777137
https://pubmed.ncbi.nlm.nih.gov/26777137